Geerts, H., Wikswo, J., van der Graaf, P. H., Bai, J. P., Gaiteri, C., Bennett, D., … & Pelleymounter, M. (2020). Quantitative systems pharmacology for neuroscience drug discovery and development: current status, opportunities, and challenges. CPT: pharmacometrics & systems pharmacology, 9(1), 5-20.
Keywords: neurophenomenology, neurofeedback, multiscale neural dynamics, downward causation, voluntary action Citation: Bagdasaryan J and Le Van Quyen M (2013) Experiencing your brain: neurofeedback as a new bridge between neuroscience and phenomenology. Front. Hum. Neurosci. 7:680. doi: 10.3389/fnhum.2013.00680
doi: 10.1016/j.schres.2016.07.014 SCHIZOPHRENIA RESEARCH 2016 Karl Friston, Harriet R. Brown, Jakob Siemerkus, Klaas E. Stephan Twenty years have passed since the dysconnection hypothesis was first proposed (Friston and Frith, 1995; Weinberger, 1993). In that time, neuroscience has witnessed tremendous advances: we now live in a world of non-invasive neuroanatomy, computational neuroimaging and the Bayesian brain. …
We desperately act in ways that are less and less driven by our real values, and that are increasingly driven by our need to be valued. Maybe that anxious, phrenetic energy undermines our ability to stop, reflect, and think. Maybe the best way that we can do to functionally manage is to seek refuge in the comfort of categorical simplicity and binaries: of dramatic hero-villain narratives.